Status:

UNKNOWN

Integrated Microfluidic Systems for Diagnosis of Periprosthetic Joint Infection

Lead Sponsor:

Chang Gung Memorial Hospital

Conditions:

Prosthetic Joint Infection

Eligibility:

All Genders

20-90 years

Brief Summary

Diagnosing periprosthetic joint infection (PJI) remains a major clinical challenge. The diagnosis of PJI is based on a composition of clinical judgment, serologic test from peripheral blood, synovial ...

Eligibility Criteria

Inclusion

  • Revision total knee arthroplasty
  • Revision total hip arthroplasty
  • Sufficiently annotated clinical and laboratory data for classification by the 2018 ICM criteria for PJI
  • Sufficient synovial fluid for study methods.

Exclusion

  • Inadequate synovial fluid for analysis
  • Adverse local tissue reaction (ALTR)
  • Crystalline deposition arthropathy
  • Inflammatory arthropathy flare

Key Trial Info

Start Date :

April 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 31 2022

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04056780

Start Date

April 1 2020

End Date

May 31 2022

Last Update

August 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan, 833

Integrated Microfluidic Systems for Diagnosis of Periprosthetic Joint Infection | DecenTrialz